Business Context and Reporting Period
Company: National Presto Industries, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: July 2, 2006
Reporting Status: This filing contains restated financial information differing from a previously filed Form 8-K. Restatements involve the reclassification of 7-day variable rate demand notes to marketable securities, adjustments to goodwill and product liability reserves, and final allocation of the Amron purchase price. The filing was signed on October 9, 2007, following a delay in filing due to a reaudit necessitated by a change in independent auditors.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended July 2, 2006 |
Three Months Ended July 3, 2005 |
Six Months Ended July 2, 2006 |
Six Months Ended July 3, 2005 |
|---|---|---|---|---|
| Net Sales | $58,014 | $34,669 | $103,067 | $70,028 |
| Gross Profit | $8,911 | $4,931 | $14,195 | $10,071 |
| Gross Margin % | 15.4% | 14.2% | 13.8% | 14.4% |
| Operating Profit | $3,815 | $713 | $4,114 | $994 |
| Net Earnings | $3,614 | $1,574 | $5,532 | $2,850 |
| Diluted EPS | $0.53 | $0.23 | $0.81 | $0.42 |
| Cash & Equivalents | Balance Sheet Data (in thousands) July 2, 2006: $36,431 Dec 31, 2005: $62,023 |
|||
| Marketable Securities | ||||
| Total Current Assets | $235,091 (2006) vs $253,225 (2005) | |||
| Total Current Liabilities | $44,617 (2006) vs $40,504 (2005) | |||
| Working Capital | $190,474 (2006) | |||
| Current Ratio | 5.3 to 1.0 (2006) |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated net sales increased 67% ($23.3M) for the quarter and 47% ($33.0M) for the six months compared to the prior year.
- Defense Products: Sales surged 208% ($18.6M) in the quarter, driven by the acquisition of Amron, LLC and increased U.S. Army 40mm Systems program sales.
- Absorbent Products: Sales rose 33% ($3.0M) due to increased adult incontinence product sales.
- Housewares: Sales increased 10% ($1.7M) due to higher unit shipments.
- Profitability: Net earnings increased 130% ($2.0M) for the quarter and 94% ($2.7M) for the six months. Operating profit jumped significantly due to Defense segment expansion.
- Absorbent Segment Loss: Despite sales growth, this segment reported a gross loss of $1.1M (quarter) and $2.9M (six months) due to material costs, depreciation, and startup inefficiencies from new machinery.
- Cash Flow: Net cash used in operating activities was $9.4M for the six months ended July 2, 2006, compared to $5.5M used in the prior year period. This was primarily due to increases in accounts receivable ($5.4M) and inventories ($17.0M).
- Investing Activities: Net cash used was $1.7M, largely due to the $13.8M acquisition of Amron, LLC.
- Dividends: Cash dividends declared and paid were $2.12 per share for the six months ended July 2, 2006, compared to $1.67 in the prior year.
Guidance, Outlook, Risks, and Unusual Items
- Acquisition Integration: The company acquired Amron, LLC in January 2006 for an adjusted purchase price of $22.4M. The earn-out obligation was settled in Q2 2007 for $2.4M.
- Plant Consolidation: In October 2006, the company decided to consolidate adult incontinence production from Marietta, GA, to Eau Claire, WI. Estimated costs are $1.02M ($829k for equipment relocation, $190k for termination benefits).
- Legal Proceedings (SEC Litigation): The SEC sued the company alleging it operated as an unregistered investment company. In May 2007, the 7th Circuit Court of Appeals reversed the lower court, ruling the company is not an investment company. This decision is final.
- Audit Delay: The controversy caused the previous auditor (Grant Thornton LLP) to withdraw, necessitating a reaudit of 2003-2005 and delaying filings. The company met the NYSE extension deadline for the 2006 10-K on August 27, 2007.
- Liquidity: The company maintains substantial liquidity with cash and short-term marketable securities. However, $35.8M of variable rate demand notes are classified as marketable securities rather than cash equivalents, which management believes understates true liquidity.
- Commitments: Open equipment/facility purchase commitments were approximately $4.4M for Defense and $0.7M for Absorbent products as of July 2, 2006.
- Accounting Changes: The company is evaluating the impact of new standards FIN 48 (Income Taxes), SFAS 157 (Fair Value), and SFAS 159 (Fair Value Option). Adoption of SFAS 158 (Pension Plans) is not expected to be material as the pension plan was terminated in 2004.
Investor Verification Checklist
- Restatement Impact: Verify the specific adjustments made to the balance sheet and cash flow statement regarding the reclassification of variable rate demand notes and the Amron purchase price allocation.
- Absorbent Segment Viability: Monitor the Absorbent Products segment closely; it is currently operating at a loss due to startup costs and material inefficiencies despite revenue growth.
- Legal Finality: Confirm the status of the SEC litigation appeal (noted as final in the text) and ensure no further regulatory hurdles remain regarding the company's classification.
- Working Capital Trends: Review the significant increase in inventory ($17M increase in cash flow usage) and accounts receivable to ensure these are aligned with sales growth and not indicative of obsolescence or collection issues.
- Dividend Sustainability: Assess the ability to maintain the increased dividend payout ($2.12/share for six months) given the cash outflows from operations and capital expenditures.